2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
January 22nd, 2025
Version: 1
Medical Univeristy of Vienna
cancer biology
biorxiv

Enhanced AkaLuc Bioluminescence Imaging for Longitudinal Intravital Monitoring of Minimal Residual Disease in a Murine Model of Triple-negative Breast Cancer

Steinbauer, S.Open in Google Scholar•Cowles, J. D.Open in Google Scholar•Sabbaghi, M. A.Open in Google Scholar•Poppelaars, M.Open in Google Scholar•Hussain, A.Open in Google Scholar•Wagesreither, M.Open in Google Scholar•Laimer-Gruber, D.Open in Google Scholar•Tovari, J.Open in Google Scholar•Szakacs, G.Open in Google Scholar•Csiszar, A.Open in Google Scholar

Triple-negative breast cancer (TNBC) is an aggressive form of cancer with poor prognosis. Beyond the absence of targeted therapies, a major challenge is its high recurrence rate, driven by the outgrowth of residual tumor cells that survive chemotherapy and persist during minimal residual disease (MRD). To monitor the therapy response of TNBC by enhanced intravital imaging, we established a clinically relevant combination chemotherapy protocol for the treatment of mouse mammary tumors engrafted from K14cre;Brca1F/F;Trp53F/F (KB1P) organoids engineered to express an mCherry-AkaLuc dual reporter (mCA-KB1P). Reproducible MRD and relapse response patterns with significantly extended relapse-free survivals were achieved with the TAC protocol, consisting of docetaxel, doxorubicin and cyclophosphamide. AkaLuc bioluminescence imaging (AkaBLI) of mCA-KB1P organoids verified the single-cell sensitivity of the system in vitro, and showed a detection limit of approximately 1000 cells in the mammary gland of living mice. Unexpectedly, mCA-KB1P organoids elicited an immune response, which necessitated the use of immunodeficient hosts for the longitudinal intravital monitoring of MRD. AkaBLI and an adapted TAC protocol enabled, for the first time, the non-invasive intravital tracking and an estimation of the number of surviving tumor cells in the MRD state following intensive chemotherapy. Engineering KB1P organoids for Histon2B-mCherry reporter expression (HmC-KB1P) enabled the estimation of tumor cell survival also in syngeneic immunocompetent hosts. Flow cytometry and histological analysis revealed that immunocompetent hosts harbored only a few residual cells at MRD, which exhibited a transient loss of epithelial characteristics, whereas immunodeficient hosts had a greater number of surviving cells with a maintained epithelial phenotype. These findings are consistent with a role of the immune system in shaping phenotypic changes influencing survival following chemotherapy. Together, the results demonstrate the utility of the AkaBLI system for rare tumor cell tracking and highlight the role of the immune system in triggering adaptive responses to chemotherapy.

Similar Papers

biorxiv
Tue Apr 01 2025
Designed Peptides as Affinity Ligands for Extracellular-Vesicle-based Cancer Biomarker Detection
Assays for cancer diagnosis via the analysis of tumor biomarkers on circulating extracellular vesicles (EVs) have shown great potential. Single EV imaging that can measure the abundance of protein biomarkers in EVs can help in detecting the presence, stage, and progression of disease. Antibodies are typically used to detect EV proteins. Controlling the quality of antibody-based immunoassays can, h...
Sarma, S.
•
Cho, Y.
•
Tapdiya, A.
•
Park, J.
...•
Hall, C. K.
biorxiv
Tue Apr 01 2025
Total whole-arm chromosome losses predict malignancy in human cancer
Aneuploidy is observed as gains or losses of whole chromosomes or chromosome arms and is a common hallmark of cancer. Whereas models for the generation of aneuploidy in cancer invoke mitotic chromosome segregation errors, whole-arm losses might occur simply as a result of centromere breakage. We recently showed that elevated RNA Polymerase II (RNAPII) level over S-phase-dependent histone genes pre...
Zheng, Y.
•
Ahmad, K.
•
Henikoff, S.
biorxiv
Tue Apr 01 2025
Interplay between BET Proteins and the Pre-Replication Complex Unveils Therapeutic Vulnerabilities in Cancer
Replication stress is a critical event in cancer development and understanding the underlying molecular mechanisms can help to identify new treatment strategies. Here, we investigate the molecular interplay between the pre-replication complex (pre-RC) and the bromodomain and extraterminal domain (BET) proteins in orchestrating replication stress response. Our findings reveal a mutual dependency be...
Doberstein, K.
•
Messner, V.
•
Berlit, S.
•
Tuschy, B.
...•
Marme, F.
biorxiv
Tue Apr 01 2025
Single-cell profiling of CAR-T CD19 cell phenotypes and immune system dynamics in pediatric BCP-ALL
Background Chimeric Antigen Receptor T-cell (CAR-T) therapy targeting CD19 has transformed the treatment of relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However, the phenotypic heterogeneity of CAR+ T-cells and their interactions with the immune system remain poorly understood. Here, we characterize CAR+ T-cell subsets and persistence in patients receiving standard-...
Oszer, A.
•
Pawlik, B.
•
Cwilichowska-Puslecka, N.
•
Marschollek, P.
...•
Mlynarski, W.
biorxiv
Tue Apr 01 2025
FMO4 drives lung adenocarcinoma by stabilizing the MAT2A/MAT2B complex and hindering ferroptosis
Lung cancer is the leading cause of death by cancer in the world and finding new targets is a major medical need to tackle this disease. Here, upon proteomic analysis to identify common players in oncogenic EGFR- and KRAS-driven lung adenocarcinoma mouse models, we uncovered a largely unknown protein in cancer, flavin-containing monooxygenase 4 (FMO4), whose expression was increased in lung tumors...
Bracquemond, D.
•
Mahdizadeh, S. J.
•
Brunet, L.
•
Thomas, Q. D.
...•
Maraver, A.
biorxiv
Tue Apr 01 2025
Divergent Therapeutic and Prognostic Impacts of Immunogenic Features in Undifferentiated Soft Tissue Sarcoma and Myxofibrosarcoma
Myxofibrosarcoma and undifferentiated soft tissue sarcoma (USTS) are genetically complex soft tissue sarcomas with distinct morphological features. Treatment typically involves surgery, often combined with neoadjuvant chemo- or radiotherapy. To better understand the immunobiology of these sarcomas and its associations with treatment response and prognosis, we performed transcriptomic and immunophe...
van Oost, S.
•
Meijer, D. M.
•
Erdem, Z. B.
•
IJsselsteijn, M. E.
...•
Bovee, J. V. M. G.
biorxiv
Tue Apr 01 2025
The SRG RAT supports human cell xenotransplantation through enhanced tumor microenvironment interactions
The use of immunodeficient mice for human tumor engraftment is an essential model of human cancer, with uses ranging from basic science to translational research. However, low engraftment rates, slow growth, and smaller tumor volumes can be limitations. Previously, we reported a highly immunodeficient rat strain with the functional deletion of both the Rag2 and Il2rg genes on the Sprague-Dawley ba...
O'Connor, C. M.
•
Zawacki, K. P.
•
Durrant, J. R.
•
Barrie, K.
...•
Narla, G.
biorxiv
Tue Apr 01 2025
Synergic microRNAs suppress human glioblastoma progression by modulating clinically relevant targets
Glioblastoma (GBM) is a highly aggressive brain tumor characterized by therapy-resistant glioma stem-like cells (GSCs) and extensive infiltration into surrounding brain tissue. MicroRNAs (miRNAs) are post-transcriptional regulators of oncogenic pathways, but their tumor-suppressive function is frequently lost in GBM. This study explores a multimodal therapeutic approach by restoring a combination ...
Rancati, S.
•
Pereira, R. C.
•
Schlich, M.
•
Sgroi, S.
...•
Tonelli, D. D. P.
biorxiv
Tue Apr 01 2025
CDK12 condensation in nuclear speckles confers sensitivity to cyclin K molecular glue degraders
Transcriptional machinery often operates in the configuration of biomolecular condensates, presenting emerging opportunities to develop therapies targeting transcriptionally addicted malignancies. In this study, we discovered that cyclin-dependent kinase 12 (CDK12), a key regulator of transcription elongation, formed dynamic liquid-like droplets within nuclear speckles, a process enhanced by high ...
Ye, K.
•
He, Q.
•
Cheng, Y.
•
Zhang, M.
...•
Tan, L.
biorxiv
Tue Apr 01 2025
Antigen-presenting cancer-associated fibroblasts in murine pancreatic tumors differentially control regulatory T cell phenotype and function via CXCL9 and CCL22
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a complex tumor microenvironment (TME) including stromal cells that influence resistance to therapy. Recent studies have revealed that stromal cancer-associated fibroblasts (CAFs) are heterogeneous in origin, gene expression, and function. Antigen-presenting CAFs (apCAFs), are defined by major histocompatibility complex (MHC)-II expressio...
Maru, S. Y.
•
Wetzel, M.
•
Mitchell, J. T.
•
Gross, N. E.
...•
Jaffee, E. M.